Optogenetics: Exciting inhibition in primates

A new genetic marker enables precise control over a group of inhibitory neurons in monkeys.
  1. Wim Vanduffel  Is a corresponding author
  2. Xiaolian Li
  1. Department of Neurosciences, KU Leuven Medical School, Belgium
  2. Leuven Brain Institute, KU Leuven Medical School, Belgium
  3. Department of Radiology, Harvard Medical School, United States
  4. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, United States

At the age of 30, Louis Leborgne lost his ability to speak, and was only able to utter one syllable – ‘tan’. After his death 21 years later in 1861, a brain biopsy by his physician Paul Broca revealed that his inability to speak was caused by a lesion in the left frontal cortex, in a region of the brain now known as Broca’s area (Mohammed et al., 2018). More instructive though less known are Ernest Auburtin’s experiments on the exposed brain of a patient who had attempted suicide. When Auburtin softly pressed on specific parts of the frontal cortex, the patient lost his ability to speak, whereas his other cognitive functions remained unaffected (Stookey, 1963).

Whilst both studies showed the power of causally linking specific regions of the brain to specific behaviors, Auburtin’s experiments were more telling because of the reversible nature of his actions on an otherwise intact brain. However, these experiments – and many ‘causal’ techniques developed since then – lack spatio-temporal precision: that is, they cannot identify precisely where and when signals are produced or interrupted. Optogenetics overcomes these problems by using genetic manipulation or viral vectors to express light-sensitive proteins (such as opsins) in neurons: illumination with specific wavelengths of light can then induce neuronal responses that are precisely synchronized with the frequency of stimulation (Boyden et al., 2005). Moreover, specific cell types within a pool of diverse neurons can be precisely targeted, thereby achieving astonishing spatial resolution (Shemesh et al., 2017).

To reveal the causal relationship between a brain region and specific behavior, one can either increase local brain activity (Gerits et al., 2012), or decrease it (Afraz et al., 2015). Moreover, a region of the brain can be silenced by either inhibiting excitatory neurons or activating inhibitory neurons. A major drawback with the former approach, however, is that a period of silence induced by light is typically followed by a period of unwanted 'rebound' activity. Activating a local network of inhibitory neurons is more elegant because it takes advantage of natural inhibition in the brain and avoids the problem of rebound effects. This approach has proved successful in rodents, but efforts to translate it to primates have been limited. Recently, however, a new viral vector (Dlx5/6) that only targets inhibitory interneurons was demonstrated in multiple species, including primates (Dimidschstein et al., 2016).

Now, in eLife, Abhishek De (University of Washington), Yasmine El-Shamayleh (Columbia University) and Gregory Horwitz (University of Washington) report on the behavioral effectiveness of this approach in macaques (De et al., 2020). The researchers injected a Dlx5/6 vector carrying channelrhodopsin (an opsin that activates neurons) into the primary visual cortex of the primates and used immunohistochemical techniques to confirm that it primarily targeted inhibitory neurons that used the neurotransmitter GABA. When this region was illuminated via an optic fiber connected to an electrode, about two-thirds of the neurons increased their activity, whereas one third suppressed their activity. The latencies for the former group of neurons (that is, the interval between light stimulation and neuronal response) were short, which suggests that they were GABAergic interneurons that expressed channelrhodopsin. The latencies for the inactivated group of neurons were longer, indicating they were downstream from directly activated interneurons.

Therefore, using the new optogenetic technique to induce inhibition in the primary visual cortex (meaning this part of the cortex can no longer process visual information) should result in a temporary blind spot in the monkey’s visual field. To test this behaviorally, De, El-Shamayleh and Horwitz used a saccade test, during which they presented the monkey a point on a screen. When the position of the point overlapped with the receptive fields of the stimulated inhibitory neurons (blind spot), the monkeys were less likely to detect the stimulus (Figure 1). Also, performance on a contrast detection task was severely diminished when inhibitory neurons were activated. In this test, monkeys had to indicate (with eye movements) whether a contrast-adjusted faint stimulus was positioned either on the left or the right side of the screen. Optogenetic stimulation reduced their sensitivity to detect this cue on a grey background with the same mean luminance when the stimulus was placed inside the activated receptive fields. Thus, this experiment confirmed that optogenetics only affected the monkeys’ sensitivity to the visual stimulus, but not the ability to move their eyes.

Local visual sensitivity is reduced in macaques by activating inhibitory neurons.

A new optogenetics method can selectively stimulate inhibitory neurons and so reduce activity in a specific brain region. To test this method in macaques, De, El-Shamayleh and Horwitz injected the viral vector Dlx5/6 carrying channelrhodopsin – which activates inhibitory neurons (pink) – into the primary visual cortex of primates. Upon stimulation with light (torch), these inhibitory neurons were activated (top graph, blue line), subsequently leading to a deactivation of the excitatory neurons (grey: bottom graph, blue line). In a visual task, the monkeys were presented with a point that could appear randomly in different locations, and the subjects had to detect this point using an eye movement (green arrows). Activation of inhibitory neurons induced a blind spot in the visual field of the monkey; hence, monkeys were less likely to detect the point when it appeared in the blind spot (as indicated by the red cross). IPS: impulses per second (which corresponds to the firing rate of the neuron).

The work of De, El-Shamayleh and Horwitz constitutes another important milestone bridging the gap between research into the rodent brain and research into the monkey brain (Han et al., 2009; Gerits and Vanduffel, 2013), and it confirms that it is possible to successfully change behavior using selective activation of inhibitory neurons in primates (Dimidschstein et al., 2016). In the future, methods to reversibly control specific neurons in large brains with millisecond precision may become possible in monkeys (Marshel et al., 2019) and would allow to unravel the precise neuronal mechanisms underlying higher-order cognitive abilities unique to primates. Ultimately, it may be possible to recover lost brain functions in patients like Louis Leborgne, or patients with psychiatric disorders linked to a malfunctioning inhibitory circuitry of the brain.

References

Article and author information

Author details

  1. Wim Vanduffel

    Wim Vanduffel is in the Department of Neurosciences, KU Leuven Medical School, Leuven, Belgium, the Leuven Brain Institute, Leuven, Belgium, the Department of Radiology, Harvard Medical School, Boston, United States and the Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, United States

    For correspondence
    wim@nmr.mgh.harvard.edu
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9399-343X
  2. Xiaolian Li

    Xiaolian Li is in the Department of Neurosciences, KU Leuven Medical School, Leuven, Belgium, and the Leuven Brain Institute, Leuven, Belgium

    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3648-7554

Publication history

  1. Version of Record published: July 1, 2020 (version 1)

Copyright

© 2020, Vanduffel and Li

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,491
    views
  • 106
    downloads
  • 1
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Wim Vanduffel
  2. Xiaolian Li
(2020)
Optogenetics: Exciting inhibition in primates
eLife 9:e59381.
https://doi.org/10.7554/eLife.59381

Further reading

    1. Biochemistry and Chemical Biology
    2. Neuroscience
    Katarzyna Marta Zoltowska, Utpal Das ... Lucía Chávez-Gutiérrez
    Research Article

    Amyloid β (Aβ) peptides accumulating in the brain are proposed to trigger Alzheimer’s disease (AD). However, molecular cascades underlying their toxicity are poorly defined. Here, we explored a novel hypothesis for Aβ42 toxicity that arises from its proven affinity for γ-secretases. We hypothesized that the reported increases in Aβ42, particularly in the endolysosomal compartment, promote the establishment of a product feedback inhibitory mechanism on γ-secretases, and thereby impair downstream signaling events. We conducted kinetic analyses of γ-secretase activity in cell-free systems in the presence of Aβ, as well as cell-based and ex vivo assays in neuronal cell lines, neurons, and brain synaptosomes to assess the impact of Aβ on γ-secretases. We show that human Aβ42 peptides, but neither murine Aβ42 nor human Aβ17–42 (p3), inhibit γ-secretases and trigger accumulation of unprocessed substrates in neurons, including C-terminal fragments (CTFs) of APP, p75, and pan-cadherin. Moreover, Aβ42 treatment dysregulated cellular homeostasis, as shown by the induction of p75-dependent neuronal death in two distinct cellular systems. Our findings raise the possibility that pathological elevations in Aβ42 contribute to cellular toxicity via the γ-secretase inhibition, and provide a novel conceptual framework to address Aβ toxicity in the context of γ-secretase-dependent homeostatic signaling.

    1. Computational and Systems Biology
    2. Neuroscience
    Sara Ibañez, Nilapratim Sengupta ... Christina M Weaver
    Research Article

    Normal aging leads to myelin alterations in the rhesus monkey dorsolateral prefrontal cortex (dlPFC), which are positively correlated with degree of cognitive impairment. It is hypothesized that remyelination with shorter and thinner myelin sheaths partially compensates for myelin degradation, but computational modeling has not yet explored these two phenomena together systematically. Here, we used a two-pronged modeling approach to determine how age-related myelin changes affect a core cognitive function: spatial working memory. First, we built a multicompartment pyramidal neuron model fit to monkey dlPFC empirical data, with an axon including myelinated segments having paranodes, juxtaparanodes, internodes, and tight junctions. This model was used to quantify conduction velocity (CV) changes and action potential (AP) failures after demyelination and subsequent remyelination. Next, we incorporated the single neuron results into a spiking neural network model of working memory. While complete remyelination nearly recovered axonal transmission and network function to unperturbed levels, our models predict that biologically plausible levels of myelin dystrophy, if uncompensated by other factors, can account for substantial working memory impairment with aging. The present computational study unites empirical data from ultrastructure up to behavior during normal aging, and has broader implications for many demyelinating conditions, such as multiple sclerosis or schizophrenia.